Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | meclocycline | 54676539 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | carteolol | 2583 | drug-path |
| Cell cycle | R-HSA-1640170 | map04110 | carteolol | 2583 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | carteolol | 2583 | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | carteolol | 2583 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | carteolol | 2583 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | carteolol | 2583 | drug-path |
| T cell receptor signaling pathway | R-HSA-983705 | map04660 | carteolol | 2583 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | carteolol | 2583 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | carteolol | 2583 | drug-path |
| Renal cell carcinoma | R-HSA-9794523 | map05211 | digitoxigenin | 14052 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | digitoxigenin | 14052 | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | digitoxigenin | 14052 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | digitoxigenin | 14052 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | digitoxigenin | 14052 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | digitoxigenin | 14052 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | digitoxigenin | 14052 | drug-path |
| Cardiac muscle contraction | R-HSA-397014 | map04260 | digitoxigenin | 14052 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | digitoxigenin | 14052 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | digitoxigenin | 14052 | drug-path |